This House Resolution supports designating the week of April 11 through April 17, 2026, as "Black Maternal Health Week." The resolution aims to bring national attention to the maternal and reproductive health crisis in the United States, specifically highlighting the importance of reducing maternal mortality and morbidity among Black women and birthing people.
The RECOVER Act of 2026 seeks to eliminate a specific payment reduction under the Medicare program, directly affecting Medicare beneficiaries who receive multiple therapy services and the providers who furnish them. Currently, Medicare applies a 50% payment reduction when certain multiple therapy services are provided to a beneficiary on the same day. This bill amends existing law to eliminate that 50% reduction, changing it to 0 percent. This change applies to therapy services billed under the physician fee schedule, as well as outpatient and comprehensive outpatient rehabilitation services, and will take effect for services furnished on or after January 1, 2027.
The Answering the Call Act of 2026 aims to improve access and outreach for the 9-8-8 National Suicide Prevention Lifeline specifically for first responders, including law enforcement, firefighters, and EMTs. It directs the Secretary of Health and Human Services to conduct outreach activities, in coordination with first responder organizations, to promote 9-8-8 and address barriers like stigma and privacy concerns. The bill also authorizes grants for public awareness campaigns, mandates specialized trauma-informed training for 9-8-8 counselors to serve first responders, and requires data collection on their hotline use with privacy safeguards. Additionally, it establishes a pilot program for federal agencies and first responder organizations to collaborate on tailoring these outreach efforts.
This bill amends the Higher Education Act of 1965 to expand the definition of "institution of higher education" for certain graduate medical schools located outside the United States. This change affects these foreign medical schools and their students, potentially making more students eligible for federal student loans. The bill adds an alternative criterion for schools to qualify: they must have had a clinical training program approved by a U.S. state (requiring an on-site visit) as of January 31, 2021, and continue to operate such a program in at least one U.S. state with state approval. This is in addition to the existing criterion that at least 60% of their students and graduates are not U.S. citizens or eligible non-citizens.
The National Food as Medicine Program Act of 2026 proposes to establish a federal grant program for states to create or expand "Food as Medicine" initiatives under Medicaid waivers. These programs would provide medically supportive food and nutrition interventions, like tailored meals or produce prescriptions, to Medicaid-eligible individuals with nutrition-related chronic conditions or food insecurity. The bill also directs the Department of Agriculture to provide technical assistance to farmers, especially socially disadvantaged and beginning farmers, to help them supply regeneratively or organically produced local food to these programs. Furthermore, it mandates federal guidance for states on implementing these programs, including eligibility criteria, provider roles, and procurement methods, aiming to integrate food interventions into healthcare.
HR 8261, the Chronic Care Management Improvement Act of 2026, aims to reduce healthcare costs for Medicare Part B beneficiaries receiving chronic care management services. Effective January 1, 2027, the bill mandates that Medicare will cover 100% of the cost for these specific services. This means individuals will no longer be responsible for any copayments or deductibles for chronic care management. The change directly affects Medicare Part B enrollees who utilize these services, making them more affordable by eliminating out-of-pocket costs.
The Veterinary Services to Improve Public Health in Rural Communities Act authorizes the Indian Health Service (IHS) to provide public health veterinary services, such as spaying/neutering, vaccinations, and disease surveillance, to prevent and control zoonotic diseases (diseases transmissible between animals and humans) in Tribal communities. The bill allows for the deployment of veterinary public health officers to these areas and coordination with agencies like the CDC and USDA. Additionally, it mandates a study by the Department of Agriculture on the feasibility and efficacy of delivering oral rabies vaccines to wildlife in Arctic regions to protect Tribal members. Finally, the act formally includes the Director of the IHS in the federal government's "One Health" framework, which emphasizes the interconnectedness of human, animal, and environmental health.
This resolution expresses the House of Representatives' support for designating March 2026 as Endometriosis Awareness Month. It recognizes the need for early detection, increased education for healthcare providers, and continued research into endometriosis, a chronic disease affecting women. The resolution encourages the people of the United States to observe the month with appropriate awareness and educational activities.
The "Accountable Produce is Medicine Act of 2026" mandates the creation of a new pilot program within the Center for Medicare and Medicaid Innovation. This program requires selected healthcare providers to offer a comprehensive set of "Accountable Produce is Medicine services" to eligible Medicare, Medicaid, and CHIP beneficiaries. These services, provided without patient cost-sharing, include healthy foods (like fruits and vegetables), nutrition counseling, care coordination, and remote monitoring for individuals with specific chronic diseases in underserved areas. Participating programs will screen patients, deliver these services for a year, and track health data to evaluate outcomes and cost savings over a period of at least five years.
This bill, titled the "Drug Origin Transparency Act of 2026," aims to increase transparency regarding the manufacturing and supply chain of drugs, primarily affecting drug manufacturers and suppliers of active pharmaceutical ingredients. It mandates that drug manufacturers submit more detailed and frequent reports to the government, identifying suppliers of active pharmaceutical ingredients and intermediate materials, including the amounts sourced from each. These reports could be required up to four times annually. Additionally, the bill requires drug labels to include the name, place of business, and unique facility identifier of the original manufacturer of both the finished drug and its active pharmaceutical ingredients. Labels must also identify all manufacturers involved, from the original active ingredient supplier to the final packer or distributor.